Xiaofeng Wu

3.5k total citations · 1 hit paper
105 papers, 2.0k citations indexed

About

Xiaofeng Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiaofeng Wu has authored 105 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 25 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Xiaofeng Wu's work include Cancer-related molecular mechanisms research (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and RNA modifications and cancer (8 papers). Xiaofeng Wu is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and RNA modifications and cancer (8 papers). Xiaofeng Wu collaborates with scholars based in China, United States and Singapore. Xiaofeng Wu's co-authors include Xiang Xu, Luoquan Ao, Wei Xing, Wei Guo, Mengwei Yao, Xiang Ao, Zhao–You Tang, Xueting Hu, Yu Yang and Chengxiu Pu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaofeng Wu

97 papers receiving 2.0k citations

Hit Papers

METTL3/IGF2BP3 axis inhibits tumor immune surveillance by... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer
    2022 276 citations Weijun Wan, Xiang Ao et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Wu China 24 899 456 430 339 231 105 2.0k
Wen Xu China 18 1.2k 1.3× 375 0.8× 326 0.8× 339 1.0× 233 1.0× 37 2.1k
Wei Tan China 30 1.1k 1.2× 376 0.8× 551 1.3× 483 1.4× 197 0.9× 94 2.2k
Jiahong Xia China 23 1.1k 1.2× 308 0.7× 462 1.1× 438 1.3× 261 1.1× 89 2.5k
Fabio F. di Mola Italy 26 792 0.9× 660 1.4× 316 0.7× 207 0.6× 197 0.9× 59 2.2k
Paola Bendinelli Italy 23 701 0.8× 344 0.8× 206 0.5× 132 0.4× 81 0.4× 49 1.7k
Dimitrios C. Ziogas Greece 26 755 0.8× 913 2.0× 142 0.3× 301 0.9× 217 0.9× 99 2.2k
Małgorzata Milkiewicz Poland 28 1.1k 1.2× 317 0.7× 501 1.2× 116 0.3× 185 0.8× 80 2.5k
Yu‐Wen Su China 25 826 0.9× 242 0.5× 285 0.7× 526 1.6× 157 0.7× 72 2.0k

Countries citing papers authored by Xiaofeng Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Wu more than expected).

Fields of papers citing papers by Xiaofeng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Wu. The network helps show where Xiaofeng Wu may publish in the future.

Co-authorship network of co-authors of Xiaofeng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Wu. A scholar is included among the top collaborators of Xiaofeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Wu. Xiaofeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Ying, Xiaofeng Wu, Yuan Liu, et al.. (2025). Effect of Elderly Donors on Long-Term Outcomes of Liver Transplantation: A Retrospective Cohort Study.. Experimental and Clinical Transplantation. 23(2). 120–132. 1 indexed citations
3.
Jiang, Aimin, Wenqiang Liu, Qiwei Yang, et al.. (2024). TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study. SHILAP Revista de lepidopterología. 4(4). 382–394. 3 indexed citations
4.
Jing, Taile, Fei Guo, Zongqin Zhang, et al.. (2024). Robot-assisted single-port retroperitoneal partial nephrectomy with a novel purpose-built single-port robotic system with deformable surgical instruments. World Journal of Urology. 42(1). 134–134. 8 indexed citations
5.
Hou, Peng, Linling Cheng, Wenliang Guo, et al.. (2024). Comparison of [18F]FAPI-42 and [18F]FDG PET/CT in the evaluation of systemic vasculitis. European Journal of Nuclear Medicine and Molecular Imaging. 52(3). 1083–1094. 9 indexed citations
6.
Liu, Yiwei, Ke Shao, Qi Shen, et al.. (2024). Phosphorylated FOXQ1, a novel substrate of JNK1, inhibits sorafenib-induced ferroptosis by activating ETHE1 in hepatocellular carcinoma. Cell Death and Disease. 15(6). 395–395. 6 indexed citations
7.
Shen, Lin, et al.. (2023). Altered gut microbiota profile in patients with perimenopausal panic disorder. Frontiers in Psychiatry. 14. 1139992–1139992. 4 indexed citations
8.
Liu, Qiuping, Jie Tang, Yizhang Chen, et al.. (2023). Immuno-genomic-radiomics to predict response of biliary tract cancer to camrelizumab plus GEMOX in a single-arm phase II trial. JHEP Reports. 5(7). 100763–100763. 3 indexed citations
9.
Wu, Zuotian, Yang Zhao, Dong Zhao, et al.. (2023). Intermittent hypoxia exacerbated depressive and anxiety-like behaviors in the bleomycin-induced pulmonary fibrosis mice. Brain Research Bulletin. 198. 55–64. 4 indexed citations
10.
11.
Hou, Peng, Wenliang Guo, Penghao Chen, et al.. (2023). Preliminary study on the short-term changes of pulmonary perfusion after a single balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Therapeutic Advances in Respiratory Disease. 17. 2683791635–2683791635. 1 indexed citations
12.
Hong, Cheng, Riken Chen, Haimin Liu, et al.. (2023). Aetiological distribution of pulmonary hypertension and the value of transthoracic echocardiography screening in the respiratory department: A retrospective analysis from China. The Clinical Respiratory Journal. 17(6). 536–547. 3 indexed citations
13.
Ma, Zijian, Changxian Li, Wangjie Jiang, et al.. (2022). The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers. Nature Communications. 13(1). 38 indexed citations
14.
Wan, Weijun, Xiang Ao, Quan Chen, et al.. (2022). METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer. Molecular Cancer. 21(1). 60–60. 276 indexed citations breakdown →
15.
Liu, Wei, Ling Zhou, Xiaofeng Wu, et al.. (2022). Development and Validation of a Prognostic Nomogram in Lung Cancer With Obstructive Sleep Apnea Syndrome. Frontiers in Medicine. 9. 810907–810907. 7 indexed citations
16.
Wu, Xiaofeng, et al.. (2021). A Novel Prognostic and Predictive Signature for Lung Adenocarcinoma Derived from Combined Hypoxia and Infiltrating Immune Cell-Related Genes in TCGA Patients. International Journal of General Medicine. Volume 14. 10467–10481. 4 indexed citations
17.
Li, Jianying, Xiaofeng Wu, Jianxiong Lin, et al.. (2016). Type D personality, illness perception, social support and quality of life in continuous ambulatory peritoneal dialysis patients. Psychology Health & Medicine. 22(2). 196–204. 12 indexed citations
18.
Zhang, Min, Feifei Luo, Yufei Zhang, et al.. (2014). Pseudomonas aeruginosa Mannose-Sensitive Hemagglutinin Promotes T-Cell Response via Toll-Like Receptor 4–Mediated Dendritic Cells to Slow Tumor Progression in Mice. Journal of Pharmacology and Experimental Therapeutics. 349(2). 279–287. 22 indexed citations
19.
Guo, Qunying, Chunyan Yi, Jianying Li, et al.. (2013). Prevalence and Risk Factors of Fluid Overload in Southern Chinese Continuous Ambulatory Peritoneal Dialysis Patients. PLoS ONE. 8(1). e53294–e53294. 62 indexed citations
20.
Shen, Hui, T Kihara, Xiaofeng Wu, et al.. (2010). Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of α7 nicotinic receptors and internalization of NMDA receptors. British Journal of Pharmacology. 161(1). 127–139. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen Xu Breakdown of academic impact, for papers by Wei Tan Breakdown of academic impact, for papers by Jiahong Xia Breakdown of academic impact, for papers by Fabio F. di Mola Breakdown of academic impact, for papers by Paola Bendinelli Breakdown of academic impact, for papers by Dimitrios C. Ziogas Breakdown of academic impact, for papers by Małgorzata Milkiewicz Breakdown of academic impact, for papers by Yu‐Wen Su
Rankless by CCL
2026